Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

921 recalls · Class II, newest first

Class II · Moderate risk

CAREONE Allergy Relief

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Terminated Impurity / degradation Perrigo Company PLC NDC 41520-229-39 D-0334-2022
Class II · Moderate risk

berkley jensen

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Terminated Impurity / degradation Perrigo Company PLC D-0333-2022
Class II · Moderate risk

basic+care

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Terminated Impurity / degradation Perrigo Company PLC NDC 0113-7425-78 D-0332-2022
Class II · Moderate risk

basic+care

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Terminated Impurity / degradation Perrigo Company PLC NDC 0113-7571-47 D-0331-2022
Class II · Moderate risk

amazon

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Terminated Impurity / degradation Perrigo Company PLC D-0330-2022
Class II · Moderate risk

GoodSense Aller.Ease

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Terminated Impurity / degradation Perrigo Company PLC D-0329-2022
Class II · Moderate risk

Cholestene capsules

Marketed Without an Approved NDA/ANDA

Terminated Unapproved drug High Performance Formulas, L.L.C. (HPF, L.L.C.) D-0727-2021
Class II · Moderate risk

Miss Slim

Marketed without ANDA/NDA approval

Ongoing Other His Enterprise INC D-0770-2021
Class II · Moderate risk

Tizanidine HCl Tablets

Failed Tablet/Capsule Specification: Some tablets are shaved

Terminated Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-180-15 D-0750-2021

Recalls by year